GuidelineBMC medicine2025
Reporting guideline for Chatbot Health Advice studies: the CHART statement.
Guideline in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Audiologist-Guided Multimodal AI for Pure-Tone Audiometry and Tympanometry Interpretation and Reporting.Journal of medical systems · 2026Article
- Bridging the Health Literacy Gap for Patients With Oral Cancer: Readability Enhancement With AI Chatbots.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026Article
- Evaluating the quality of artificial intelligence responses to psoriasis-related clinical and patient questions: a comparative study of ChatGPT, Gemini, and Microsoft Copilot.Proceedings (Baylor University. Medical Center) · 2026Article
- Bedside Triage by Large Language Models in Acute Pancreatitis: A Scenario-Based Comparative Evaluation of GPT-4, GPT-5, and Gemini.World journal of surgery · 2026Article
- Performance of 5 Large Language Models in Perioperative Consultation for Pediatric Hypospadias: Cross-Sectional Comparative Study.Journal of medical Internet research · 2026Article
- Benchmarking large language models for congenital cataract parent counseling: safety, readability, and knowledge translation of developmental and genetic information.Frontiers in cell and developmental biology · 2026Article
- Risk-centered benchmarking of large language models for AI-enabled counseling in chronic autoimmune thyroid eye disease.Frontiers in cell and developmental biology · 2026Article
- Article
- Can Large Language Models Identify When an Upper Extremity Problem Needs Nonurgent Attention? An Assessment of Multiple LLM Chatbots.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
47 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Chatbot Assessment Reporting Tool (CHART) is a reporting guideline developed to provide reporting recommendations for studies evaluating the performance of generative artificial intelligence (AI)-driven chatbots when summarizing clinical evidence and providing health advice, referred to as Chatbot Health Advice (CHA) studies.
methodsCHART was developed in several phases after performing a comprehensive systematic review to identify variation in the conduct, reporting, and methodology in CHA studies. Findings from the review were used to develop a draft checklist that was revised through an international, multidisciplinary modified asynchronous Delphi consensus process of 531 stakeholders, three synchronous panel consensus meetings of 48 stakeholders, and subsequent pilot testing of the checklist.
resultsCHART includes 12 items and 39 subitems to promote transparent and comprehensive reporting of CHA studies. These include Title (subitem 1a), Abstract/Summary (subitem 1b), Background (subitems 2ab), Model Identifiers (subitems 3ab), Model Details (subitems 4abc), Prompt Engineering (subitems 5ab), Query Strategy (subitems 6abcd), Performance Evaluation (subitems 7ab), Sample Size (subitem 8), Data Analysis (subitem 9a), Results (subitems 10abc), Discussion (subitems 11abc), Disclosures (subitem 12a), Funding (subitem 12b), Ethics (subitem 12c), Protocol (subitem 12d), and Data Availability (subitem 12e).
conclusionThe CHART checklist and corresponding methodological diagram were designed to support key stakeholders including clinicians, researchers, editors, peer reviewers, and readers in reporting, understanding, and interpreting the findings of CHA studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.